HUP0303333A3 - Combination comprising a signal transduction inhibitor and an epothilone derivative and pharmaceutical composition containing it - Google Patents

Combination comprising a signal transduction inhibitor and an epothilone derivative and pharmaceutical composition containing it

Info

Publication number
HUP0303333A3
HUP0303333A3 HU0303333A HUP0303333A HUP0303333A3 HU P0303333 A3 HUP0303333 A3 HU P0303333A3 HU 0303333 A HU0303333 A HU 0303333A HU P0303333 A HUP0303333 A HU P0303333A HU P0303333 A3 HUP0303333 A3 HU P0303333A3
Authority
HU
Hungary
Prior art keywords
combination
pharmaceutical composition
composition containing
signal transduction
transduction inhibitor
Prior art date
Application number
HU0303333A
Other languages
Hungarian (hu)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2002/002049 external-priority patent/WO2002067941A2/en
Publication of HUP0303333A2 publication Critical patent/HUP0303333A2/en
Publication of HUP0303333A3 publication Critical patent/HUP0303333A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
HU0303333A 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative and pharmaceutical composition containing it HUP0303333A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0104840.4A GB0104840D0 (en) 2001-02-27 2001-02-27 Use of organic compounds
PCT/EP2002/002049 WO2002067941A2 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative

Publications (2)

Publication Number Publication Date
HUP0303333A2 HUP0303333A2 (en) 2004-01-28
HUP0303333A3 true HUP0303333A3 (en) 2004-05-28

Family

ID=9909622

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303333A HUP0303333A3 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative and pharmaceutical composition containing it

Country Status (5)

Country Link
CZ (1) CZ20032277A3 (en)
GB (1) GB0104840D0 (en)
HU (1) HUP0303333A3 (en)
TW (2) TWI303170B (en)
ZA (1) ZA200306404B (en)

Also Published As

Publication number Publication date
ZA200306404B (en) 2004-06-07
CZ20032277A3 (en) 2004-01-14
HUP0303333A2 (en) 2004-01-28
TW200602060A (en) 2006-01-16
GB0104840D0 (en) 2001-04-18
TWI303170B (en) 2008-11-21
TWI343258B (en) 2011-06-11

Similar Documents

Publication Publication Date Title
IL156759A0 (en) Kits and pharmaceutical compositions containing epothilone derivatives
IL158523A0 (en) Epothilone derivatives and pharmaceutical compositions containing the same
IL156988A0 (en) Pharmaceutical compositions containing epothilone derivatives
HUP0400327A3 (en) Azole derivatives having metalloproteinase inhibitor effect pharmaceutical compositions containing them and their use
IL157128A0 (en) Pharmaceutical compositions containing epothilone derivatives
EP1383743A4 (en) Dual inhibitors of pde 7 and pde 4
HUP0300497A3 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
IL152078A0 (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
HUP0400328A3 (en) Metalloproteinase inhibitor azoles and pharmaceutical compositions containing them
HUP0400206A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect a their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them
IL158083A0 (en) A PHARMACEUTICAL COMPOSITION CONTAINING AN Eg5 PROTEIN INHIBITOR
HUP0303621A3 (en) Pharmaceutical compositions containing combinations comprising an antidiarrheal agent and epothilone or an epothilone
AU2002231570A1 (en) Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AP2004002963A0 (en) Pharmaceutical compositions of amlodipine and atorvastatin.
IL156577A0 (en) Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
TWI315982B (en) Combinations comprising epothilones and pharmaceutical uses thereof
EP1541139A4 (en) Drug composition containing nf-kappa b inhibitor
GB0008328D0 (en) Pressure sensitive adhesive compositions
AU2003212457A1 (en) Derivatives of epothilone b and d and synthesis thereof
EP1663201A4 (en) A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
IL158058A0 (en) Combination of a taxane and a cyclin-dependent kinase inhibitor
EP1467978A4 (en) Pancreatic lipase inhibitor compounds, their synthesis and use
HUP0303333A3 (en) Combination comprising a signal transduction inhibitor and an epothilone derivative and pharmaceutical composition containing it

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees